Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > PFUDA 10/3 Date

<< Previous

Bullboard Posts

Next >>

Post by PWIB123on Aug 18, 2022 11:01am

206 Views

Post# 34904753

PFUDA 10/3 Date

Someone on Yahoo Finance and Stocktwits posted something about a 10/3 date. This is not something I have any knowledge on, but after some quick research, there are investors that follow these dates. I cannot verify it, and I'm not exactly sure what it might mean. Any of you experts know?

<< Previous

Bullboard Posts

Next >>

This company starts production at what could be Canada’s next great gold mine